716 related articles for article (PubMed ID: 11708418)
1. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
Jacobsen S; Ullman S; Shen GQ; Wiik A; Halberg P
J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies in systemic sclerosis.
Steen VD
Semin Arthritis Rheum; 2005 Aug; 35(1):35-42. PubMed ID: 16084222
[TBL] [Abstract][Full Text] [Related]
3. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
Hamaguchi Y
J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
[TBL] [Abstract][Full Text] [Related]
4. Determinants of morbidity and mortality of systemic sclerosis in Canada.
Al-Dhaher FF; Pope JE; Ouimet JM
Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
[TBL] [Abstract][Full Text] [Related]
5. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.
Perera A; Fertig N; Lucas M; Rodriguez-Reyna TS; Hu P; Steen VD; Medsger TA
Arthritis Rheum; 2007 Aug; 56(8):2740-6. PubMed ID: 17665460
[TBL] [Abstract][Full Text] [Related]
6. Anti-th/to-positivity in a cohort of patients with idiopathic pulmonary fibrosis.
Fischer A; Pfalzgraf FJ; Feghali-Bostwick CA; Wright TM; Curran-Everett D; West SG; Brown KK
J Rheumatol; 2006 Aug; 33(8):1600-5. PubMed ID: 16783860
[TBL] [Abstract][Full Text] [Related]
7. [Scleroderma--systemic sclerosis. Serology, lung function and survival].
Ullman S; Halberg P; Wiik A; Jacobsen S
Ugeskr Laeger; 1999 May; 161(21):3084-90. PubMed ID: 10377851
[TBL] [Abstract][Full Text] [Related]
8. Survival and causes of death in 366 Hungarian patients with systemic sclerosis.
Czirják L; Kumánovics G; Varjú C; Nagy Z; Pákozdi A; Szekanecz Z; Szucs G
Ann Rheum Dis; 2008 Jan; 67(1):59-63. PubMed ID: 17519276
[TBL] [Abstract][Full Text] [Related]
9. Renal function is mostly preserved in patients with systemic sclerosis.
Scheja A; Bartosik I; Wuttge DM; Hesselstrand R
Scand J Rheumatol; 2009; 38(4):295-8. PubMed ID: 19214870
[TBL] [Abstract][Full Text] [Related]
10. Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital.
Joven BE; Almodovar R; Carmona L; Carreira PE
Semin Arthritis Rheum; 2010 Feb; 39(4):285-93. PubMed ID: 19782387
[TBL] [Abstract][Full Text] [Related]
11. Associations of right ventricular myocardial function with skin and pulmonary involvement in asymptomatic patients with systemic sclerosis.
D'Andrea A; Bellissimo S; Scotto di Uccio F; Vigorito F; Moscato F; Tozzi N; Di Donato M; Citro R; Stisi S; Scherillo M
Ital Heart J; 2004 Nov; 5(11):831-9. PubMed ID: 15633438
[TBL] [Abstract][Full Text] [Related]
12. Juvenile systemic sclerosis: report of three cases and review of Japanese published work.
Aoyama K; Nagai Y; Endo Y; Ishikawa O
J Dermatol; 2007 Sep; 34(9):658-61. PubMed ID: 17727371
[TBL] [Abstract][Full Text] [Related]
13. Relationship between occupational risk factors and severity markers of systemic sclerosis.
Magnant J; de Monte M; Guilmot JL; Lasfargues G; Diot P; Asquier E; Degenne D; Boissinot E; Diot E
J Rheumatol; 2005 Sep; 32(9):1713-8. PubMed ID: 16142866
[TBL] [Abstract][Full Text] [Related]
14. Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study.
Nihtyanova SI; Tang EC; Coghlan JG; Wells AU; Black CM; Denton CP
QJM; 2010 Feb; 103(2):109-15. PubMed ID: 19966313
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive diagnostic and functional evaluation of cardiac and pulmonary involvement in systemic sclerosis.
Sergiacomi G; De Nardo D; Capria A; Manenti G; Fabiano S; Borzi M; De Sanctis G; Konda D; Sperandio M; Schillaci O; Masala S; Simonetti G; Fontana L
In Vivo; 2004; 18(2):229-35. PubMed ID: 15113051
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of soluble CD31 in patients with systemic sclerosis (SSc): association with limited cutaneous SSc.
Sato S; Komura K; Hasegawa M; Fujimoto M; Takehara K
J Rheumatol; 2001 Nov; 28(11):2460-5. PubMed ID: 11708419
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
[TBL] [Abstract][Full Text] [Related]
18. Investigation of prognostic factors for skin sclerosis and lung function in Japanese patients with early systemic sclerosis: a multicentre prospective observational study.
Hasegawa M; Asano Y; Endo H; Fujimoto M; Goto D; Ihn H; Inoue K; Ishikawa O; Kawaguchi Y; Kuwana M; Muro Y; Ogawa F; Sasaki T; Takahashi H; Tanaka S; Takehara K; Sato S
Rheumatology (Oxford); 2012 Jan; 51(1):129-33. PubMed ID: 22072085
[TBL] [Abstract][Full Text] [Related]
19. A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement.
Mitri GM; Lucas M; Fertig N; Steen VD; Medsger TA
Arthritis Rheum; 2003 Jan; 48(1):203-9. PubMed ID: 12528120
[TBL] [Abstract][Full Text] [Related]
20. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
DeMarco PJ; Weisman MH; Seibold JR; Furst DE; Wong WK; Hurwitz EL; Mayes M; White B; Wigley F; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Clements PJ
Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
